Bliss GVS Pharma Ltd (BLISSGVS) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 730684, "name": "Bliss GVS Pharma", "stock_name": "Bliss GVS Pharma", "full_name": "Bliss GVS Pharma Ltd", "name_url": "stocks-analysis/bliss-gvs-pharma", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "488.80", "chg": 11.7, "chgp": "2.45%", "dir": 1, "prev_price": "477.10", "mcapval": "5,193.21 Cr", "mcap": "Small Cap", "scripcode": 506197, "symbol": "BLISSGVS", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE416D01022", "curr_date": "Aug 10, 10:39 AM", "curr_time": "10:41 AM", "last_traded_at": "Aug 10, 10:39 AM IST", "bse_nse_vol": "70.84 k", "exc_status": "Active", "traded_date": "Aug 10, 2026", "traded_date_str": "2026 08 10", "score": "", "scoreText": "", "Live": 1, "market_time": 1, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/bliss-gvs-pharma-730684-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "Bliss GVS Pharma Gains 2.08%: 4 Key Factors Driving the Week’s Momentum", "link": "https://www.marketsmojo.com/news/stocks-in-action/bliss-gvs-pharma-gains-208-4-key-factors-driving-the-weeks-momentum-4143436", "imagepath": "", "date": "2026-08-08 16:00:07", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>3 Aug:</strong> Technical momentum shifts signal bullish outlook</p>\n <p><strong>4 Aug:</strong> Hits upper circuit amid strong buying pressure</p>\n <p><strong>5 Aug:</strong> Bullish momentum shift confirmed with strong technical signals</p>\n <p><strong>6-7 Aug:</strong> Price correction amid mixed volume and market trends</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.467.40</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs...." }, { "title": "Bliss GVS Pharma Ltd is Rated Hold", "link": "https://www.marketsmojo.com/news/stock-recommendation/bliss-gvs-pharma-ltd-is-rated-hold-4142961", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/BlissGVSPharmaL_mojoScore_4142961.png", "date": "2026-08-08 10:10:04", "description": "Bliss GVS Pharma Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 12 Nov 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 08 August 2026, providing investors with an up-to-date perspective on the stock’s fundamentals, valuation, financial trends, and technical outlook." }, { "title": "When is the next results date for Bliss GVS Pharma Ltd?", "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-bliss-gvs-pharma-ltd-4140491", "imagepath": "", "date": "2026-08-06 23:18:46", "description": "The next results date for Bliss GVS Pharma Ltd is scheduled for 12 August 2026...." }, { "title": "Bliss GVS Pharma Ltd Sees Bullish Momentum Shift Amid Strong Technical Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/bliss-gvs-pharma-ltd-sees-bullish-momentum-shift-amid-strong-technical-signals-4137019", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/BlissGVSPharmaL_technicaldot_4137019.png", "date": "2026-08-05 08:04:21", "description": "Bliss GVS Pharma Ltd has demonstrated a significant shift in technical momentum, moving from a mildly bullish to a bullish stance, supported by robust signals across multiple indicators including MACD, Bollinger Bands, and moving averages. This technical evolution coincides with a strong price performance that outpaces the broader Sensex, signalling renewed investor confidence in this small-cap pharmaceutical player." }, { "title": "Bliss GVS Pharma Ltd Locks at Upper Circuit With 4.41% Gain — Buyers Queue, Sellers Absent", "link": "https://www.marketsmojo.com/news/stocks-in-action/bliss-gvs-pharma-ltd-hits-upper-circuit-amid-strong-buying-pressure-4135580", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/BlissGVSPharmaL_stocks_hitting_upper_circuit_4135580.png", "date": "2026-08-04 11:00:14", "description": "At Rs 489.75, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Bliss GVS Pharma Ltd locked at its upper circuit of 4.41% on 4 Aug 2026, with buyers queuing and no sellers willing to part with shares." }, { "title": "Bliss GVS Pharma Ltd Technical Momentum Shifts Amid Mixed Indicator Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/bliss-gvs-pharma-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-4134887", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/BlissGVSPharmaL_technicaldot_4134887.png", "date": "2026-08-04 08:06:44", "description": "Bliss GVS Pharma Ltd has experienced a nuanced shift in its technical momentum, moving from a bullish to a mildly bullish stance as of early August 2026. Despite a slight dip in daily price, the stock’s broader technical indicators present a complex picture, with mixed signals from MACD, RSI, and moving averages suggesting cautious optimism for investors navigating the Pharmaceuticals & Biotechnology sector." }, { "title": "Bliss GVS Pharma Ltd Technical Momentum Shifts Signal Bullish Outlook", "link": "https://www.marketsmojo.com/news/stocks-in-action/bliss-gvs-pharma-ltd-technical-momentum-shifts-signal-bullish-outlook-4132913", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/BlissGVSPharmaL_technicaldot_4132913.png", "date": "2026-08-03 08:02:05", "description": "Bliss GVS Pharma Ltd has witnessed a notable shift in its technical momentum, upgrading from a mildly bullish to a bullish trend. Supported by strong weekly and monthly MACD signals and daily moving averages, the pharmaceutical small-cap is demonstrating renewed investor interest despite mixed short-term returns compared to the broader Sensex." }, { "title": "Bliss GVS Pharma Ltd Technical Momentum Shifts Amid Mixed Market Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/bliss-gvs-pharma-ltd-technical-momentum-shifts-amid-mixed-market-signals-4129528", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/BlissGVSPharmaL_technicaldot_4129528.png", "date": "2026-07-31 08:01:46", "description": "Bliss GVS Pharma Ltd has experienced a nuanced shift in its technical momentum, moving from a bullish to a mildly bullish stance as of late July 2026. Despite a slight dip in daily price, key indicators such as MACD and KST maintain bullish signals on weekly and monthly charts, while moving averages and Bollinger Bands suggest cautious optimism. This article analyses the evolving technical landscape of this small-cap pharmaceutical stock, contextualising its performance against broader market trends and providing a comprehensive view for investors." }, { "title": "Bliss GVS Pharma Ltd is Rated Hold", "link": "https://www.marketsmojo.com/news/stock-recommendation/bliss-gvs-pharma-ltd-is-rated-hold-4124240", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/BlissGVSPharmaL_mojoScore_4124240.png", "date": "2026-07-28 10:10:03", "description": "Bliss GVS Pharma Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 12 Nov 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 28 July 2026, providing investors with an up-to-date view of its fundamentals, returns, and market performance." } ], "total": 403, "sid": "730684", "stock_news_url": "https://www.marketsmojo.com/news/bliss-gvs-pharma-730684" }, "announcements": [ { "caption": "Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Wednesday August 12 2026", "datetime": "05-Aug-2026", "details": "Bliss GVS Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 inter alia to consider and approve Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that a meeting of the Board of Directors of the Company will be held on Wednesday August 12 2026 at the registered office of the Company to consider and approve inter alia the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30 2026.", "source": "BSE" }, { "caption": "Pre-Offer Advertisement & Corrigendum to Detailed Public Statement", "datetime": "27-Jul-2026", "details": "SBI Capital Markets Ltd (Manager to the Open Offer) has submitted to BSE a copy of Pre-Offer Advertisement in accordance with Regulation 18(7) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations 2011 as amended and Corrigendum to the Detailed Public Statement for the attention of the Public Shareholders of Bliss GVS Pharma Ltd (Target Company).", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Cessation", "datetime": "24-Jul-2026", "details": "Please find attached detailed intimation regarding resignation of Mr. Sachin Saboo Senior Management Personnel of the Company pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "", "data": [ { "title": "BOARD MEETING", "txt": "12 Aug 2026" } ] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Bliss GVS Pharma Ltd has declared <strong>100%</strong> dividend, ex-date: 08 Jul 26", "dt": "2026-07-08", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "", "data": [ { "txt": "Bliss GVS Pharma Ltd has announced <strong>1:10</strong> stock split, ex-date: 11 Mar 08", "dt": "2008-03-11", "middle_text": "Split" } ] }, { "img": "bonus.svg", "title": "BONUS", "msg": "", "data": [ { "txt": "Bliss GVS Pharma Ltd has announced <strong>3:5</strong> bonus issue, ex-date: 26 Sep 08", "dt": "2008-09-26", "middle_text": "Bonus Alert" } ] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

3 Aug: Technical momentum shifts signal bullish outlook

4 Aug: Hits upper circuit amid strong buying pressure

5 Aug: Bullish momentum shift confirmed with strong technical signals

6-7 Aug: Price correction amid mixed volume and market trends

Read full news article

Bliss GVS Pharma Ltd is Rated Hold

2026-08-08 10:10:04

Bliss GVS Pharma Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 12 Nov 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 08 August 2026, providing investors with an up-to-date perspective on the stock’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

When is the next results date for Bliss GVS Pharma Ltd?

2026-08-06 23:18:46

The next results date for Bliss GVS Pharma Ltd is scheduled for 12 August 2026....

Read full news article

Bliss GVS Pharma Ltd Sees Bullish Momentum Shift Amid Strong Technical Signals

2026-08-05 08:04:21

Bliss GVS Pharma Ltd has demonstrated a significant shift in technical momentum, moving from a mildly bullish to a bullish stance, supported by robust signals across multiple indicators including MACD, Bollinger Bands, and moving averages. This technical evolution coincides with a strong price performance that outpaces the broader Sensex, signalling renewed investor confidence in this small-cap pharmaceutical player.

Read full news article

Bliss GVS Pharma Ltd Locks at Upper Circuit With 4.41% Gain — Buyers Queue, Sellers Absent

2026-08-04 11:00:14

At Rs 489.75, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Bliss GVS Pharma Ltd locked at its upper circuit of 4.41% on 4 Aug 2026, with buyers queuing and no sellers willing to part with shares.

Read full news article

Bliss GVS Pharma Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

2026-08-04 08:06:44

Bliss GVS Pharma Ltd has experienced a nuanced shift in its technical momentum, moving from a bullish to a mildly bullish stance as of early August 2026. Despite a slight dip in daily price, the stock’s broader technical indicators present a complex picture, with mixed signals from MACD, RSI, and moving averages suggesting cautious optimism for investors navigating the Pharmaceuticals & Biotechnology sector.

Read full news article

Bliss GVS Pharma Ltd Technical Momentum Shifts Signal Bullish Outlook

2026-08-03 08:02:05

Bliss GVS Pharma Ltd has witnessed a notable shift in its technical momentum, upgrading from a mildly bullish to a bullish trend. Supported by strong weekly and monthly MACD signals and daily moving averages, the pharmaceutical small-cap is demonstrating renewed investor interest despite mixed short-term returns compared to the broader Sensex.

Read full news article

Bliss GVS Pharma Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-07-31 08:01:46

Bliss GVS Pharma Ltd has experienced a nuanced shift in its technical momentum, moving from a bullish to a mildly bullish stance as of late July 2026. Despite a slight dip in daily price, key indicators such as MACD and KST maintain bullish signals on weekly and monthly charts, while moving averages and Bollinger Bands suggest cautious optimism. This article analyses the evolving technical landscape of this small-cap pharmaceutical stock, contextualising its performance against broader market trends and providing a comprehensive view for investors.

Read full news article

Bliss GVS Pharma Ltd is Rated Hold

2026-07-28 10:10:03

Bliss GVS Pharma Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 12 Nov 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 28 July 2026, providing investors with an up-to-date view of its fundamentals, returns, and market performance.

Read full news article